-
1
-
2Academic Journal
Authors: Kodirova Saodat Maham qizi
-
3
-
4
-
5
-
6Academic Journal
Source: Медицина в Кузбассе, Vol 24, Iss 1, Pp 61-72 (2025)
Subject Terms: ингибиторы протонной помпы, лекарственная безопасность, побочные эффекты, н2-гистаминоблокаторы, Medicine
File Description: electronic resource
-
7Academic Journal
Source: Медицина в Кузбассе, Vol 24, Iss 1, Pp 61-72 (2025)
-
8Academic Journal
Authors: P. A. Galenko-Yaroshevsky, I. Y. Torshin, A. N. Gromov, I. A. Reyer, O. A. Gromova, B. A. Trofimov, L. N. Parshina, R. A. Murashko, O. V. Shelemekh, A. V. Zadorozhniy, V. L. Popkov, A. V. Zelenskaya, I. B. Nektarevskaya, A. V. Sergeeva, A. V. Uvarov, Yu. V. Tovkach, I. V. Sholl, П. А. Галенко-Ярошевский, И. Ю. Торшин, А. Н. Громов, И. А. Рейер, О. А. Громова, Б. А. Трофимов, Л. Н. Паршина, Р. А. Мурашко, О. В. Шелемех, А. В. Задорожний, В. Л. Попков, А. В. Зеленская, И. Б. Нектаревская, А. В. Сергеева, А. В. Уваров, Ю. В. Товкач, И. В. Шоль
Source: FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology; Vol 18, No 2 (2025); 248-260 ; ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология; Vol 18, No 2 (2025); 248-260 ; 2070-4933 ; 2070-4909
Subject Terms: интеллектуальный анализ данных, pilim-1, zinc, gastroprojection, side effects, intellectual data analysis, пилим-1, цинк, гастропротекция, побочные эффекты
File Description: application/pdf
Relation: https://www.pharmacoeconomics.ru/jour/article/view/1180/601; Громова О.А., Торшин И.Ю., Путилина М.В. и др. Хемореактомный анализ центральных механизмов нестероидных противовоспалительных препаратов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020; 120 (1): 70–7. https://doi.org/10.17116/jnevro202012001170.; Galenko-Yaroshevsky P.A., Torshin I.Y., Gromov A.N., et al. Chemoproteomic analysis of the promising candidate molecule of the indole derivative with lab code SV-1010 and other non-steroidal anti-inflammatory drugs. Res Results Pharmacol. 2024; 10 (3): 1–9. https://doi.org/10.18413/rrpharmacology.10.497.; Santos L.H., Feres C.A., Melo F.H., et al. Anti-inflammatory, antinociceptive and ulcerogenic activity of a zinc-diclofenac complex in rats. Braz J Med Biol Res. 2004; 37 (8): 1205–13. https://doi.org/10.1590/s0100-879x2004000800011.; Sukul A., Poddar S.K., Haque S., et al. Synthesis, characterization and comparison of local analgesic, anti-inflammatory, anti-ulcerogenic activity of copper and zinc complexes of indomethacin. Antiinflamm Antiallergy Agents Med Chem. 2017; 15 (3): 221–33. https://doi.org/10.2174/1871523016666170217103402.; Jarosz M., Szkaradek N., Marona H., et al. Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats. Inflammopharmacology. 2017; 25 (6): 653–63. https://doi.org/10.1007/s10787-017-0361-0.; Gaweł M., Lipkowska A., Herman M., et al. Chronic treatment with zinc hydroaspartate induces anti-inflammatory and anti-ulcerogenic activity in rats. Pharmacol Rep. 2014; 66 (5): 862–6. https://doi.org/10.1016/j.pharep.2014.05.007.; Torshin I.Yu. Sensing the change from molecular genetics to personalized medicine. Nova Science Pub Inc; 2012: 366 pp.; Torshin I.Y. On solvability, regularity, and locality of the problem of genome annotation. Pattern Recognit Image Anal. 2010; 20: 386–95. https://doi.org/10.1134/S1054661810030156.; Торшин И.Ю. О задачах оптимизации, возникающих при применении топологического анализа данных к поиску алгоритмов прогнозирования с фиксированными корректорами. Информатика и еe применения. 2023; 17 (2): 2–10. https://doi.org/10.14357/19922264230201.; Торшин И.Ю. О применении топологического подхода к анализу плохо формализуемых задач для построения алгоритмов виртуального скрининга квантово-механических свойств органических молекул I: основы проблемно ориентированной теории. Информатика и ее применения. 2022; 16 (1): 39–44. https://doi.org/10.14357/19922264220106.; Торшин И.Ю., Громова О.А., Стаховская Л.В., Семёнов В.А. Хемореактомный анализ молекул толперизона, тизанидина и баклофена: холинолитические, спазмолитические и анальгетические механизмы действия. Неврология, нейропсихиатрия, психосоматика. 2018; 10 (4): 72–80. https://doi.org/10.14412/2074-2711-2018-4-72-80.; Громова О.А., Торшин И.Ю. Микронутриенты и репродуктивное здоровье. 2-е изд. М.: ГЭОТАР-Медиа; 2022: 832 c.; Reiterer G., Toborek M., Hennig B. Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J Nutr. 2004; 134 (7): 1711–5. https://doi.org/10.1093/jn/134.7.1711.; Baumgardner K.R., Sulfaro M.A. The anti-inflammatory effects of human recombinant copper-zinc superoxide dismutase on pulp inflammation. J Endod. 2001; 27 (3): 190–5. https://doi.org/10.1097/00004770-200103000-00014.; Громова О.А., Торшин И.Ю., Пронин А.В., Кильчевский М.А. Синергидное применение цинка и витамина С для поддержки памяти, внимания и снижения риска развития заболеваний нервной системы. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (7): 112–9. https://doi.org/10.17116/jnevro201711771112-119.; Громова О.А. Торшин И.Ю. Важность цинка для поддержания активности белков врожденного противовирусного иммунитета: анализ публикаций, посвященных COVID-19. Профилактическая медицина. 2020; 23 (3): 131–9. https://doi.org/10.17116/profmed202023031131.; Prasad A.S. Zinc is an antioxidant and anti-inflammatory agent: its role in human health. Front Nutr. 2014; 1: 14. https://doi.org/10.3389/fnut.2014.00014.; Громова О.А., Торшин И.Ю., Моисеев В.С. и др. Об использовании цинка и витамина С для профилактики и адъювантной терапии острых респираторных заболеваний. Терапия. 2017; 1 (11): 36–46.; Briassoulis G., Briassoulis P., Ilia S., et al. The anti-oxidative, anti-inflammatory, anti-apoptotic, and anti-necroptotic role of zinc in COVID-19 and sepsis. Antioxidants. 2023; 12 (11): 1942. https://doi.org/10.3390/antiox12111942.; Gaweł M., Librowski T., Lipkowska A. Influence of zinc hydroaspartate on the anti-inflammatory and gastric activity of ketoprofen in rats. Pharmacol Rep. 2013; 65 (1): 214–9. https://doi.org/10.1016/s1734-1140(13)70981-2.; Hessam S., Sand M., Meier N.M., et al. Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa. J Dermatol Sci. 2016; 84 (2): 197–202. https://doi.org/10.1016/j.jdermsci.2016.08.010.; Chen Y., Cai J., Liu D., et al. Zinc-based metal organic framework with antibacterial and anti-inflammatory properties for promoting wound healing. Regen Biomater. 2022; 9: rbac019. https://doi.org/10.1093/rb/rbac019.; Guo J., He L., Li T., et al. Antioxidant and anti-inflammatory effects of different zinc sources on diquat-induced oxidant stress in a piglet model. Biomed Res Int. 2020; 2020: 3464068. https://doi.org/10.1155/2020/3464068.; Mei X., Xu D., Xu S., et al. Gastroprotective and antidepressant effects of a new zinc(II)-curcumin complex in rodent models of gastric ulcer and depression induced by stresses. Pharmacol Biochem Behav. 2011; 99 (1): 66–74. https://doi.org/10.1016/j.pbb.2011.04.002.; Mei X., Luo X., Xu S., et al. Gastroprotective effects of a new zinc(II)-curcumin complex against pylorus-ligature-induced gastric ulcer in rats. Chem Biol Interact. 2009; 181 (3): 316–21. https://doi.org/10.1016/j.cbi.2009.06.022.; Bandyopadhyay B., Bandyopadhyay S.K. Protective effect of zinc gluconate on chemically induced gastric ulcer. Indian J Med Res. 1997; 106: 27–32.; Golbabapour S., Gwaram N.S., Hassandarvish P., et al. Gastroprotection studies of Schiff base zinc (II) derivative complex against acute superficial hemorrhagic mucosal lesions in rats. PLoS One. 2013; 8 (9): e75036. https://doi.org/10.1371/journal.pone.0075036.; Yu C., Mei X.T., Zheng Y.P., Xu D.H. Gastroprotective effect of taurine zinc solid dispersions against absolute ethanol-induced gastric lesions is mediated by enhancement of antioxidant activity and endogenous PGE2 production and attenuation of NO production. Eur J Pharmacol. 2014; 740: 329–36. https://doi.org/10.1016/j.ejphar.2014.07.014.; Rainsford K.D., Whitehouse M.W. Anti-ulcer activity of a slow-release zinc complex, zinc monoglycerolate (Glyzinc). J Pharm Pharmacol. 1992; 44 (6): 476–82. https://doi.org/10.1111/j.2042-7158.1992.tb03650.x.; Bulbena O., Escolar G., Navarro C., et al. Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal antiinflammatory drugs. A morphological study. Dig Dis Sci. 1993; 38 (4): 730–9. https://doi.org/10.1007/BF01316807.; Donkin J.J., Turner R.J., Hassan I., Vink R. Substance P in traumatic brain injury. Prog Brain Res. 2007; 61: 97–109. https://doi.org/10.1016/S0079-6123(06)61007-8.; Галенко-Ярошевский П.А., Торшин И.Ю., Громов А.Н. и др. Дифференциальный хемопротеомный анализ молекулы-кандидата RRS-1 и молекул нескольких нестероидных противовоспалительных препаратов. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2024; 17 (3): 324–36. https://doi.org/10.17749/2070-4909/farmakoekonomika.2024.265.; Галенко-Ярошевский П.А., Сергеева А.В., Торшин И.Ю. и др. Хемореактомное прогнозирование противовоспалительных, противоболевых, ульцерогенных эффектов молекулы-кандидата N-аллилимидазол-цинка в сравнении с цинковыми производными нестероидных противовоспалительных препаратов. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2024; 17 (4): 523–34. https://doi.org/10.17749/2070-4909/farmakoekonomika.2024.279.; Галенко-Ярошевский П.А., Торшин И.Ю., Громов А.Н. и др. Хемореактомный анализ ацизола в сравнении с цинковыми производными нестероидных противовоспалительных препаратов. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2024; 17 (1): 48–61. https://doi.org/10.17749/2070-4909/farmakoekonomika.2024.238.; https://www.pharmacoeconomics.ru/jour/article/view/1180
-
9Academic Journal
Authors: Vladimir P. Kuzmin, Irina A. Zolotovskaya, Svetlana P. Krivova, Rais K. Khayretdinov, Violetta A. Rodionova, Olesya A. Rubanenko, Igor L. Davydkin, Владимир Петрович Кузьмин, Ирина Александровна Золотовская, Светлана Петровна Кривова, Раис Катдусович Хайретдинов, Виолетта Анатольевна Родионова, Олеся Анатольевна Рубаненко, Игорь Леонидович Давыдкин
Contributors: The authors declare no research funding.
Source: Complex Issues of Cardiovascular Diseases; Том 14, № 2 (2025); 127-135 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 2 (2025); 127-135 ; 2587-9537 ; 2306-1278
Subject Terms: Внезапная сердечная смерть, Drug-induced QT prolongation, Drug side effects, Torsades de pointes, Sudden cardiac death, Лекарственно индуцированное удлинение интервала QT, Побочные эффекты лекарственных средств, Тахикардия типа «пируэт»
File Description: application/pdf
Relation: https://www.nii-kpssz.com/jour/article/view/1540/1031; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1540/1792; Castiglione A., Odening K. QT-Zeit – Was fange ich eigentlich damit an? [QT Interval and Its Prolongation - What Does It Mean?]. Dtsch Med Wochenschr. 2020;145(8):536-542. doi:10.1055/a-0969-6312.; Uvelin A., Pejaković J., Mijatović V. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist. J Anesth. 2017;31(3):413-423. doi:10.1007/s00540-017-2314-6.; Beach S.R., Celano C.M., Sugrue A.M., Adams C., Ackerman M.J., Noseworthy P.A., Huffman JC. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics. 2018;59(2):105-122. doi:10.1016/j.psym.2017.10.009.; Урясьев О.М., Жукова Л.А., Глотов С.И., Алексеева Е.А., Максимцева Е.А Удлинение и укорочение интервала QT-предикторы внезапной сердечной смерти. Земский врач. 2020;1:27-32.; Остроумова О.Д., Голобородова И.В. Влияние отдельных групп лекарственных препаратов на риск удлинения интервала QTс. Consilium Medicum. 2019; 21 (10): 95–106. doi:10.26442/20751753.2019.10.190447; Marengoni A., Onder G. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ. 2015;350:h1059. doi:10.1136/bmj.h1059.; Marostica E., Van Ammel K., Teisman A., Boussery K., Van Bocxlaer J., De Ridder F., Gallacher D., Vermeulen A. Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities. J Pharmacokinet Pharmacodyn. 2015;42(6):659-79. doi:10.1007/s10928-015-9434-0.; Khatib R., Sabir F.R.N., Omari C., Pepper C., Tayebjee M.H. Managing drug-induced QT prolongation in clinical practice. Postgrad Med J. 2021;97(1149):452-458. doi:10.1136/postgradmedj-2020-138661.; Tan H., Yan X., Chen Y., Huang G., Luo L., Li W., Lan W., Chen C., Xi X. A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS. Front Cardiovasc Med. 2024;11:1363382. doi:10.3389/fcvm.2024.1363382.; Priori S.G., Blomstrom-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J., Elliott P.M., Fitzsimons D., et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793-2867. doi:10.1093/eurheartj/ehv316.; Al-Khatib S.M., Stevenson W.G., Ackerman M.J., Bryant W.J., Callans D.J., Curtis A.B., Deal B.J., Dickfeld T., et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018; 72: e91-e220; Dahlberg P., Diamant U.B., Gilljam T., Rydberg A., Bergfeldt L. QT correction using Bazett's formula remains preferable in long QT syndrome type 1 and 2. Ann Noninvasive Electrocardiol. 2021;26(1):e12804. doi:10.1111/anec.12804.; Yazdanpanah M.H., Naghizadeh M.M., Sayyadipoor S., Farjam M. The best QT correction formula in a non-hospitalized population: the Fasa PERSIAN cohort study. BMC Cardiovasc Disord. 2022;22(1):52. doi:10.1186/s12872-022-02502-2.; Kallergis E.M., Goudis C.A., Simantirakis E.N., Kochiadakis G.E., Vardas P.E. Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. Scientific World Journal 2012; 2012: 212178. doi:10.1100/2012/212178.; Baracaldo-Santamaría D., Llinás-Caballero K., Corso-Ramirez J.M., Restrepo C.M., Dominguez-Dominguez C.A., Fonseca-Mendoza D.J., Calderon-Ospina C.A. Genetic and molecular aspects of drug-induced QT interval prolongation. Int J Mol Sci 2021; 22: 8090. doi:10.3390/ijms22158090.; Welten S.J.G.C., van der Heijden A.A., Remmelzwaal S., Blom M.T., Nijpels G., Rutters F., Beulens J.W.J., Elders P.J.M.; ESCAPE-NET investigators. Prolongation of the QTc interval is associated with an increased risk of cardiovascular diseases: The Hoorn study. J Electrocardiol. 2023;80:133-138. doi:10.1016/j.jelectrocard.2023.06.001.; Vandael E., Vandenberk B., Vandenberghe J., Willems R., Foulon V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2017;39(1):16-25. doi:10.1007/s11096-016-0414-2.; Lopez-Medina A.I., Chahal C.A.A., Luzum JA. The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants. Pharmacogenomics. 2022;23(9):543-557. doi:10.2217/pgs-2022-0027.; Valentin J.P., Hoffmann P., Ortemann-Renon C., Koerner J., Pierson J., Gintant G., Willard J., Garnett C., Skinner M., Vargas H.M., Wisialowski T., Pugsley M.K. The Challenges of Predicting Drug-Induced QTc Prolongation in Humans. Toxicol Sci. 2022;187(1):3-24. doi:10.1093/toxsci/kfac013.; Masnoon N., Shakib S., Kalisch-Ellett L., Caughey G.E. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-2.; Li D., Chai S., Wang H., Dong J., Qin C., Du D., Wang Y., Du Q., Liu S. Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database. Front Pharmacol. 2023;14:1259611. doi:10.3389/fphar.2023.1259611.; Kahlon S.S., Sikandar R., Tejovath S., Nair S., Hassan D., Patel K., Peddemul A., Mostafa J.A. Diagnosing Torsades De Pointes Based on Correlation to QT Interval: A Systematic Review. Cureus. 2022;14(8):e27833. doi:10.7759/cureus.27833.; Berger F.A., van der Sijs H., van Gelder T., van den Bemt P.M.L.A. The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies. Ther Adv Drug Saf. 2021;12:2042098621996098. doi:10.1177/2042098621996098.; Tay K.Y., Ewald M.B., Bourgeois F.T. Use of QT-prolonging medications in US emergency departments, 1995-2009. Pharmacoepidemiol Drug Saf. 2014;23(1):9-17. doi:10.1002/pds.3455.; Chaverri-Fernández J.M., Díaz-Madriz J.P., Zavaleta-Monestel E., Cordero-García E., Fallas-Mora A., Escalona-Rodríguez R. The risk of treatment-induced QT interval prolongation. Farm Hosp. 2022;46(3):116-120.; Mangona E., Sandonato E., Brothers T.N., Pawasauskas J. Drug-Induced QTc Prolongation: What We Know and Where We Are Going. Curr Drug Saf. 2022;17(2):100-113. doi:10.2174/1574886316666210922153059.; Wolfes J., Sörgel R., Ellermann C., Frommeyer G., Eckardt L. Mechanisms underlying spontaneous termination of Torsade de Pointes in an experimental model of long QT syndrome. Heart Rhythm. 2024:S1547-5271(24)03423-4. doi:10.1016/j.hrthm.2024.10.009.; Uchikawa M., Hashiguchi M., Shiga T. Drug-Induced QT Prolongation and Torsade de Pointes in Spontaneous Adverse Event Reporting: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database (2004-2021). Drugs Real World Outcomes. 2022;9(4):551-559. doi:10.1007/s40801-022-00328-0.; Tisdale J.E., Chung M.K., Campbell K.B., Hammadah M., Joglar J.A., Leclerc J., Rajagopalan B.; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020;142(15):e214-e233. doi:10.1161/CIR.0000000000000905.; Giudicessi J.R., Noseworthy P.A., Friedman P.A., Ackerman M.J. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc 2020; 95: 1213-1221. doi:10.1016/j.mayocp.2020.03.024.; Thu Kyaw M., Maung Z.M. Hypokalemia-Induced Arrhythmia: A Case Series and Literature Review. Cureus. 2022;14(3):e22940. doi:10.7759/cureus.22940.; Vehmeijer J.T., Koyak Z., Leerink J.M., Zwinderman A.H., Harris L., Peinado R., Oechslin E.N., Robbers-Visser D., Groenink M., Boekholdt S.M., de Winter R.J., Oliver J.M., Bouma B.J., Budts W., Van Gelder I.C., Mulder B.J.M., de Groot J.R. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD). Heart Rhythm. 2021;18(5):785-792. doi:10.1016/j.hrthm.2021.01.009.; Robison L.B., Brady W.J., Robison R.A., Charlton N. QT interval prolongation and the risk of malignant ventricular dysrhythmia and/or cardiac arrest: Systematic search and narrative review of risk related to the magnitude of QT interval length. Am J Emerg Med. 2021;49:40-47. doi:10.1016/j.ajem.2021.05.032.; Santoro F., Monitillo F., Raimondo P., Lopizzo A., Brindicci G., Gilio M., Musaico F., Mazzola M., Vestito D., Benedetto R.D., Abumayyaleh M., El-Battrawy I., Santoro C.R., Di Martino L.F.M., Akin I., De Stefano G., Fiorilli R., Cannone M., Saracino A., Angarano S., Carbonara S., Grasso S., Di Biase L., Brunetti N.D. QTc Interval Prolongation and Life-Threatening Arrhythmias During Hospitalization in Patients With Coronavirus Disease 2019 (COVID-19): Results From a Multicenter Prospective Registry. Clin Infect Dis. 2021;73(11):e4031-e4038. doi:10.1093/cid/ciaa1578.; Shah S.R., Park K., Alweis R. Long QT Syndrome: A Comprehensive Review of the Literature and Current Evidence. Curr Probl Cardiol. 2019;44(3):92-106. doi:10.1016/j.cpcardiol.2018.04.002.; Velcea A.E., Mihaila Baldea S., Nicula A.I., Vinereanu D. The role of multimodality imaging in the selection for implantable cardioverter-defibrillators in heart failure: A narrative review. J Clin Ultrasound. 2022;50(8):1066-1072. doi:10.1002/jcu.23281.; Donnellan E., Wazni O.M., Hanna M., Saliba W., Jaber W., Kanj M. Primary prevention implantable cardioverter-defibrillators in transthyretin cardiac amyloidosis. Pacing Clin Electrophysiol. 2020;43(11):1401-1403. doi:10.1111/pace.14023.; Khan K., Kim J.A., Gurgu A., Khawaja M., Cozma D., Chelu M.G. Innovations in Cardiac Implantable Electronic Devices. Cardiovasc Drugs Ther. 2022;36(4):763-775. doi:10.1007/s10557-021-07163-5.; Biton Y., Rosero S., Moss A.J., Goldenberg I., Kutyifa V., McNitt S., Polonsky B., Baman J.R., Zareba W. Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients. Europace. 2019;21(2):339-346. doi:10.1093/europace/euy149.; Ahsan S., Tousoulis D., Papageorgiou N. Implantable cardioverter-defibrillators: The shock "Paradox". Hellenic J Cardiol. 2020;61(6):428-429. doi:10.1016/j.hjc.2020.12.005.
-
10Academic Journal
Authors: Egorova
Subject Terms: Helicobacter pylori, eradication therapy, цинк-L-карнозин, Энтеросгель, гастропротекция, побочные эффекты, приверженность лечению
Relation: https://zenodo.org/records/16936535; oai:zenodo.org:16936535; https://doi.org/10.5281/zenodo.16936535
-
11Academic Journal
Authors: Пулатова , С.Х., Бабаджанов , О.А
Source: Eurasian Journal of Medical and Natural Sciences; Vol. 5 No. 10 (2025): Eurasian Journal of Medical and Natural Sciences; 76-80 ; Евразийский журнал медицинских и естественных наук; Том 5 № 10 (2025): Евразийский журнал медицинских и естественных наук; 76-80 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 5 Nomeri 10 (2025): Евразийский журнал медицинских и естественных наук; 76-80 ; 2181-287X
Subject Terms: Псориаз (Psoriasis),ПУВА-терапия (PUVA therapy), Узкополосная УФБ-терапия (Narrowband UVB, NB-UVB therapy), Фототерапия (Phototherapy), PASI (Psoriasis Area and Severity Index), Эффективность лечения (Treatment efficacy), Безопасность (Safety), Побочные эффекты (Adverse effects), Иммуномодулирующее действие (Immunomodulatory effect), Ремиссия (Remission duration), Psoriasis, PUVA therapy, Narrowband UVB (NB-UVB) therapy, Phototherapy, Treatment efficacy, Safety, Adverse effects, Immunomodulatory effect, Remission duration, Uzbekistan
File Description: application/pdf
Availability: https://in-academy.uz/index.php/EJMNS/article/view/61340
-
12Academic Journal
Source: Medicine in Kuzbass; Том 24, № 1 (2025): март; 61-72 ; Медицина в Кузбассе; Том 24, № 1 (2025): март; 61-72 ; 2588-0411 ; 1819-0901
Subject Terms: proton pump inhibitors, drug safety, side effects, H2-histamine blockers, ингибиторы протонной помпы, лекарственная безопасность, побочные эффекты, Н2-гистаминоблокаторы
File Description: text/html; application/pdf
Relation: http://mednauki.ru/index.php/MK/article/view/1221/2105; http://mednauki.ru/index.php/MK/article/view/1221/2091; http://mednauki.ru/index.php/MK/article/view/1221
Availability: http://mednauki.ru/index.php/MK/article/view/1221
-
13Academic Journal
Authors: G. Shubhankar, A. Mittal, V. K. Panwar, R. P. Ghorai, Г. Шубханкар, А. Миттал, В. К. Панвар, Р. П. Горай
Contributors: The study was not sponsored, Исследование не спонсировалось
Source: Urology Herald; Том 12, № 6 (2024); 76-82 ; Вестник урологии; Том 12, № 6 (2024); 76-82 ; 2308-6424 ; 10.21886/2308-6424-2024-12-6
Subject Terms: побочные эффекты, non-muscle invasive, BCG, BCG tolerability, intravesical therapy, adverse effects, немышечно-инвазивный, БЦЖ, переносимость БЦЖ, внутрипузырная терапия
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/983/614; Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F, eds. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0. 2012. (Accessed on July 20, 2024) URL: https://publications.iarc.fr/Databases/Iarc-Cancerbases/GLOB-OCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0-2012; Wein AJ, Kavoussi LR, Partin AW, Peters CA, eds. Campbell-Walsh Urology: 4-Volume Set. 11 th ed. Elsevier; 2016. (Accessed on July 20, 2024) URL: https://hsrc.himmelfarb.gwu.edu/books/69; Lamm DL. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Clin Infect Dis. 2000;31 Suppl 3:S86-90. DOI:10.1086/314064; Hannouneh ZA, Hijazi A, Alsaleem AA, Hami S, Kheyrbek N, Tanous F, Khaddour K, Abbas A, Alshehabi Z. Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer. Cancer Med. 2023 Dec;12(24):21944-21968. DOI:10.1002/cam4.6768; Koya MP, Simon MA, Soloway MS. Complications of intravesical therapy for urothelial cancer of the bladder. J Urol. 2006;175(6):2004-2010. DOI:10.1016/S0022-5347(06)00264-3; Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol. 1986;135(2):272-274. DOI:10.1016/s0022-5347(17)45606-0; Grabe-Heyne K, Henne C, Mariappan P, Geiges G, Pöhlmann J, Pollock RF. Intermediate and high-risk non-muscle-invasive bladder cancer : an overview of epidemiology, burden, and unmet needs. Front Oncol. 2023;13:1170124. DOI:10.3389/fonc.2023.1170124; Brausi M, Oddens J, Sylvester R, Bono A, van de Beek C, van Andel G, Gontero P, Turkeri L, Marreaud S, Collette S, Oosterlinck W. Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol. 2014;65(1):69-76. DOI:10.1016/j.eururo.2013.07.021; https://www.urovest.ru/jour/article/view/983
-
14Academic Journal
Authors: P. A. Galenko-Yaroshevsky, A. V. Sergeeva, I. Yu. Torshin, A. N. Gromov, I. A. Reyer, O. A. Gromova, B. A. Trofimov, L. N. Parshina, R. A. Murashko, A. V. Zadorozhniy, A. V. Zelenskaya, N. S. Sergeev, Yu. V. Tovkach, O. N. Gulevskaya, I. V. Sholl, П. А. Галенко-Ярошевский, А. В. Сергеева, И. Ю. Торшин, А. Н. Громов, И. А. Рейер, О. А. Громова, Б. А. Трофимов, Л. Н. Паршина, Р. А. Мурашко, А. В. Задорожний, А. В. Зеленская, Н. С. Сергеев, Ю. В. Товкач, О. Н. Гулевская, И. В. Шоль
Source: FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology; Vol 17, No 4 (2024); 523-534 ; ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология; Vol 17, No 4 (2024); 523-534 ; 2070-4933 ; 2070-4909
Subject Terms: интеллектуальный анализ данных, zinc-containing compounds, anti-inflammatory drug, adverse effects, chemoinformatics, pharmacoinformatics, data mining, цинкосодержащие соединения, противовоспалительный препарат, побочные эффекты, хемоинформатика, фармакоинформатика
File Description: application/pdf
Relation: https://www.pharmacoeconomics.ru/jour/article/view/1117/592; Shetty A., Delanerolle G., Cavalini H., et al. A systematic review and network meta-analysis of pharmaceutical interventions used to manage chronic pain. Sci Rep. 2024; 14 (1): 1621. https://doi.org/10.1038/s41598-023-49761-3.; Громова О.А., Торшин И.Ю., Путилина М.В. и др. Хемореактомный анализ центральных механизмов нестероидных противовоспалительных препаратов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020; 120 (1): 70–7. https://doi.org/10.17116/jnevro202012001170.; Ali G., Deeba F., Rashid U., et al. In vivo effects of a selected thiourea derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) against nociception, inflammation and gastric ulcerogenicity: biochemical, histopathological and in silico approaches. Biomed Pharmacother. 2024; 174: 116544. https://doi.org/10.1016/j.biopha.2024.116544.; Santos L.H., Feres C.A., Melo F.H., et al. Anti-inflammatory, antinociceptive and ulcerogenic activity of a zinc-diclofenac complex in rats. Braz J Med Biol Res. 2004; 37 (8): 1205–13. https://doi.org/10.1590/s0100-879x2004000800011.; Sukul A., Poddar S.K., Haque S., et al. Synthesis, characterization and comparison of local analgesic, anti-inflammatory, anti-ulcerogenic activity of copper and zinc complexes of indomethacin. Antiinflamm Antiallergy Agents Med Chem. 2017; 15 (3): 221–33. https://doi.org/10.2174/1871523016666170217103402.; Jarosz M., Szkaradek N., Marona H., et al. Evaluation of antiinflammatory and ulcerogenic potential of zinc-ibuprofen and zincnaproxen complexes in rats. Inflammopharmacology. 2017; 25 (6): 653–63. https://doi.org/10.1007/s10787-017-0361-0.; Gaweł M., Lipkowska A., Herman M., et al. Chronic treatment with zinc hydroaspartate induces anti-inflammatory and anti-ulcerogenic activity in rats. Pharmacol Rep. 2014; 66 (5): 862–6. https://doi.org/10.1016/j.pharep.2014.05.007.; Торшин И.Ю., Громова О.А., Федотова Л.Э., Громов А.Н. Сравнительный хемореактомный анализ декскетопрофена, кетопрофена и диклофенака. Неврология, нейропсихиатрия, психосоматика. 2018; 10 (1): 47–54. https://doi.org/10.14412/2074-2711-2018-1-47-54.; Торшин И.Ю., Громова О.А., Стаховская Л.В., Семёнов В.А. Хемореактомный анализ молекул толперизона, тизанидина и баклофена: холинолитические, спазмолитические и анальгетические механизмы действия. Неврология, нейропсихиатрия, психосоматика. 2018; 10 (4): 72–80. https://doi.org/10.14412/2074-2711-2018-4-72-80.; Торшин И.Ю. О задачах оптимизации, возникающих при применении топологического анализа данных к поиску алгоритмов прогнозирования с фиксированными корректорами. Информатика и еe применения. 2023; 17 (2): 2–10. https://doi.org/10.14357/19922264230201.; Torshin I.Yu., Rudakov K.V. On the procedures of generation of numerical features over partitions of sets of objects in the problem of predicting numerical target variables. Pattern Recognit Image Anal. 2019; 29 (4): 654–67. https://doi.org/10.1134/S1054661819040175.; Торшин И.Ю., Громова О.А., Чучалин А.Г., Журавлев Ю.И. Хемореактомный скрининг воздействия фармакологических препаратов на SARS-CoV-2 и виром человека как информационная основа для принятия решений по фармакотерапии COVID-19. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2021; 14 (2): 191–211. https://doi.org/10.17749/2070-4909/farmakoekonomika.2021.078.; Торшин И.Ю., Громова О.А. Экспертный анализ данных в молекулярной фармакологии. М.: МЦНМО; 2012: 747 с.; Baumgardner K.R., Sulfaro M.A. The anti-inflammatory effects of human recombinant copper-zinc superoxide dismutase on pulp inflammation. J Endod. 2001; 27 (3): 190–5. https://doi.org/10.1097/00004770-200103000-00014.; Громова О.А. Торшин И.Ю. Важность цинка для поддержания активности белков врожденного противовирусного иммунитета: анализ публикаций, посвященных COVID-19. Профилактическая медицина. 2020; 23 (3): 131–9. ht tps://doi.org/10.17116/profmed202023031131.; Громова О.А., Торшин И.Ю., Пронин А.В., Кильчевский М.А. Синергидное применение цинка и витамина С для поддержки памяти, внимания и снижения риска развития заболеваний нервной системы. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (7): 112–9. https://doi.org/10.17116/jnevro201711771112-119.; Prasad A.S. Zinc is an antioxidant and anti-inflammatory agent: its role in human health. Front Nutr. 2014; 1: 14. https://doi.org/10.3389/fnut.2014.00014.; Hunter J., Arentz S., Goldenberg J., et al. Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2021; 11 (11): e047474. https://doi.org/10.1136/bmjopen-2020-047474.; Briassoulis G., Briassoulis P., Ilia S., et al. The anti-oxidative, antiinflammatory, anti-apoptotic, and anti-necroptotic role of zinc in COVID-19 and sepsis. Antioxidants. 2023; 12 (11): 1942. https://doi.org/10.3390/antiox12111942.; Chen Y., Cai J., Liu D., et al. Zinc-based metal organic framework with antibacterial and anti-inflammatory properties for promoting wound healing. Regen Biomater. 2022; 9: rbac019. https://doi.org/10.1093/rb/rbac019.; Guo J., He L., Li T., et al. Antioxidant and anti-inflammatory effects of different zinc sources on diquat-induced oxidant stress in a piglet model. Biomed Res Int. 2020; 2020: 3464068. ht tp://doi.org/10.1155/2020/3464068.; Mei X., Xu D., Xu S., et al. Gastroprotective and antidepressant effects of a new zinc(II)-curcumin complex in rodent models of gastric ulcer and depression induced by stresses. Pharmacol Biochem Behav. 2011; 99 (1): 66–74. https://doi.org/10.1016/j.pbb.2011.04.002.; Mei X., Luo X., Xu S., et al. Gastroprotective effects of a new zinc(II)-curcumin complex against pylorus-ligature-induced gastric ulcer in rats. Chem Biol Interact. 2009; 181 (3): 316–21. https://doi.org/10.1016/j.cbi.2009.06.022.; Bandyopadhyay B., Bandyopadhyay S.K. Protective effect of zinc gluconate on chemically induced gastric ulcer. Indian J Med Res. 1997; 106: 27–32.; Chao H.C. Zinc deficiency and therapeutic value of zinc supplementation in pediatric gastrointestinal diseases. Nutrients. 2023; 15 (19): 4093. https://doi.org/10.3390/nu15194093.; Donkin J.J., Turner R.J., Hassan I., Vink R. Substance P in traumatic brain injury. Prog Brain Res. 2007; 161: 97–109. https://doi.org/10.1016/S0079-6123(06)61007-8.; https://www.pharmacoeconomics.ru/jour/article/view/1117
-
15Academic Journal
Authors: O. V. Finleyson, О. В. Финлейсон
Source: Neuromuscular Diseases; Том 15, № 1 (2025); 61-66 ; Нервно-мышечные болезни; Том 15, № 1 (2025); 61-66 ; 2413-0443 ; 2222-8721
Subject Terms: иммунные побочные эффекты, myocarditis, myositis, immune checkpoint inhibitors, thymoma, immune-related adverse effects, миокардит, миозит, ингибиторы иммунной контрольной точки, тимома
File Description: application/pdf
Relation: https://nmb.abvpress.ru/jour/article/view/649/415; Kaminski H.J., Sikorski P., Coronel S.I., Kusner L.L. Myasthenia gravis: The future is here. J Clin Invest 2024;134(12):e179742. DOI:10.1172/JCI179742; Safa H., Johnson D.H., Trinh V.A. et al. Immune checkpoint inhibitor related myasthenia gravis: Single center experience and systematic review of the literature. J Immunother Cancer 2019;7(1):319. DOI:10.1186/s40425-019-0774-y; Wang D.Y., Salem J.E., Cohen J.V. et al. Fatal toxic effects associated with immune checkpoint inhibitors: A systematic review and meta-analysis. JAMA Oncol 2018;4(12):1721–8. DOI:10.1001/jamaoncol.2018.3923; Dalakas M.C. Neurological complications of immune checkpoint inhibitors: What happens when you ‘take the brakes off’ the immune system. Ther Adv Neurol Disord 2018;11:1756286418799864. DOI:10.1177/1756286418799864; Suzuki S., Ishikawa N., Konoeda F. et al. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology 2017;89(11):1127–34. DOI:10.1212/WNL.0000000000004359; Moslehi J.J., Salem J.E., Sosman J.A. et al. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. Lancet 2018;391(10124):933. DOI:10.1016/S0140-6736(18)30533-6; Wu J., Fang W., Chen G. The enlightenments from ITMIG Consensus on WHO histological classification of thymoma and thymic carcinoma: Refined definitions, histological criteria, and reporting. J Thorac Dis 2016;8(4):738–43. DOI:10.21037/jtd.2016.01.84; Ruffini E., Huang J., Cilento V. et al. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol 2023;18(12):1655–71. DOI:10.1016/j.jtho.2023.09.002; МЕДИУМ. Справочник лекарственных препаратов. Пемброриа. Доступно по: https://medum.ru/pembroria-pembrolizumab.; Abdel-Wahab N., Shah M., Lopez-Olivo M.A., Suarez-Almazor M.E. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: A systematic review. Ann Intern Med 2018;168(2):121–30. DOI:10.7326/M17-2073; Brahmer J.R., Lacchetti C., Schneider B.J. et al. National Comprehensive Cancer Network. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2018;36(17):1714–68. DOI:10.1200/JCO.2017.77.6385; Guidon A.C. Lambert–Eaton myasthenic syndrome, botulism, and immune checkpoint inhibitor-related myasthenia gravis. Continuum (Minneap Minn) 2019;25(6):1785–806. DOI:10.1212/CON.0000000000000807; Basnet A., Sharma N.R., Gautam S. et al. Immune checkpoint inhibitor-induced myasthenia gravis, myocarditis, and myositis: A case report. Clin Case Rep 2024;12(6):e8968. DOI:10.1002/ccr3.8968; Pathak R., Katel A., Massarelli E. et al. Immune checkpoint inhibitor-induced myocarditis with myositis/myasthenia grav is overlap syndrome: A systematic review of cases. Oncologist 2021;26(12):1052–61. DOI:10.1002/onco.13931; https://nmb.abvpress.ru/jour/article/view/649
-
16Academic Journal
Authors: L. R. Sakaniya, I. V. Olenich, I. M. Korsunskaya, Л. Р. Сакания, И. В. Оленич, И. М. Корсунская
Source: Meditsinskiy sovet = Medical Council; № 2 (2025); 37-40 ; Медицинский Совет; № 2 (2025); 37-40 ; 2658-5790 ; 2079-701X
Subject Terms: эктоин, drug side effects, moisturizers, retinoids, inflammation, ectoine, побочные эффекты лекарств, увлажняющие средства, ретиноиды, воспаление
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/8946/7775; Lee WJ, Shim WS. Cutaneous Neuroimmune Interactions of TSLP and TRPV4 Play Pivotal Roles in Dry Skin-Induced Pruritus. Front Immunol. 2021;12:772941. https://doi.org/10.3389/fimmu.2021.772941.; White-Chu EF, Reddy M. Dry skin in the elderly: complexities of a common problem. Clin Dermatol. 2011;29(1):37–42. https://doi.org/10.1016/j.clindermatol.2010.07.005.; Hahnel E, Lichterfeld A, Blume-Peytavi U, Kottner J. The epidemiology of skin conditions in the aged: A systematic review. J Tissue Viability. 2017;26(1):20–28. https://doi.org/10.1016/j.jtv.2016.04.001.; Hahnel E, Blume-Peytavi U, Trojahn C, Dobos G, Jahnke I, Kanti V et al. Prevalence and associated factors of skin diseases in aged nursing home residents: a multicentre prevalence study. BMJ Open. 2017;7(9):e018283. https://doi.org/10.1136/bmjopen-2017-018283.; Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P. Diagnosis and treatment of xerosis cutis – a position paper. J Dtsch Dermatol Ges. 2019;17(S7):3–33. https://doi.org/10.1111/ddg.13906.; Amin R, Lechner A, Vogt A, Blume-Peytavi U, Kottner J. Molecular characterization of xerosis cutis: A systematic review. PLoS ONE. 2021;16(12):e0261253. https://doi.org/10.1371/journal.pone.0261253.; Lechner A, Lahmann N, Neumann K, Blume-Peytavi U, Kottner J. Dry skin and pressure ulcer risk: A multi-center cross-sectional prevalence study in German hospitals and nursing homes. Int J Nurs Stud. 2017;73:63–69. https://doi.org/10.1016/j.ijnurstu.2017.05.011.; Hahnel E, Blume-Peytavi U, Kottner J. Associations of dry skin, skin care habits, well-being, sleep quality and itch in nursing home residents: Results of a multicentre, observational, cross-sectional study. Nurs Open. 2019;6(4):1501–1509. https://doi.org/10.1002/nop2.351.; Mekić S, Jacobs LC, Gunn DA, Mayes AE, Ikram MA, Pardo LM, Nijsten T. Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study. J Am Acad Dermatol. 2019;81(4):963–969.e2. https://doi.org/10.1016/j.jaad.2018.12.038.; Lee JE, Chang JY, Lee SE, Kim MY, Lee JS, Lee MG, Kim SC. Epidermal Hyperplasia and Elevated HB-EGF are More Prominent in Retinoid Dermatitis Compared with Irritant Contact Dermatitis Induced by Benzalkonium Chloride. Ann Dermatol. 2010;22(3):290–299. https://doi.org/10.5021/ad.2010.22.3.290.; Петрова КС, Колбина МС. Акне и эпидермальный барьер. Клиническая дерматология и венерология. 2015;14(1):90–93. https://doi.org/10.17116/klinderma2015190-93.; Lacouture ME, Anadkat MJ, Bensadoun RJ, Bryce J, Chan A, Epstein JB et al. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer. 2011;19(8):1079–1095. https://doi.org/10.1007/s00520-011-1197-6.; Wilkes GM, Barton-Burke M. 2016 Oncology Nursing Drug Handbook. Sudbury, MA: Jones and Bartlett Publishing; 2016. Available at: https://books.google.co.zw/books?id=stOqCwAAQBAJ&printsec=copyright#v=onepage&q&f=false.; Eilers RE, Gandhi M, Patel JD, Mulcahy MF, Agulnik M, Hensing T, Lacouture ME. Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J Natl Cancer. 2010;102(1):47–53. https://doi.org/10.1093/jnci/djp439.; Huang AH, Kaffenberger BH, Reich A, Szepietowski JC, Ständer S, Kwatra SG. Pruritus Associated with Commonly Prescribed Medications in a Tertiary Care Center. Medicines. 2019;6(3):84. https://doi.org/10.3390/medicines6030084.; Кочеровец ВИ. Эктоин – секрет природы с уникальным биотерапевтическим эффектом. М.: Издат; 2021. 44 с.; Кочеровец ВИ. Эктоин – микробный метаболит с уникальными биотерапевтическими свойствами. Педиатрия. Consilium Medicum. 2019;(1):108–115. Режим доступа: https://perfectoin.ru/upload/iblock/fb4/mt7kdkpow6j3ch00vyq2l14w32hgpb7z/ektoin-mikrobnyy-metabolit-sunikalnymi-bioterapevticheskimi-svoystvami.pdf.; Huang ZR, Lin YK, Fang JY. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules. 2009;14(1):540–554. https://doi.org/10.3390/molecules14010540.; de Souza Neto AV, Balla DQ, Candido TM, Rosado C, Baby AR, Pessoa FVLS. Effect of an Emollient Emulsion Containing 15.0% of Caprylic/Capric Triglyceride on the Urocanic Acid of the Stratum Corneum. Life. 2023;13(4):876. https://doi.org/10.3390/life13040876.; Taheri M, Amiri-Farahani L. Anti-Inflammatory and Restorative Effects of Olives in Topical Application. Dermatol Res Pract. 2021;2021:9927976. https://doi.org/10.1155/2021/9927976.; Gaziano R, Campione E, Iacovelli F, Pistoia ES, Marino D, Milani M et al. Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives. Eur Rev Med Pharmacol Sci. 2019;23(16):7135–7143. https://doi.org/10.26355/eurrev_201908_18759.; Fai D, Fai C, Di Vito M, Martini C, Zilio G, De Togni H. Cardiospermum halicacabum in atopic dermatitis: Clinical evidence based on phytotherapic approach. Dermatol Ther. 2020;33(6):e14519. https://doi.org/10.1111/dth.14519.; Сакания ЛР, Бадлуева КВ, Корсунская ИМ. Роль средств ухода при аногенитальном зуде. Клиническая дерматология и венерология. 2023;22(5):606–609. https://doi.org/10.17116/klinderma202322051606.; Pastor JM, Salvador M, Argandoña M, Bernal V, Reina-Bueno M, Csonka LN et al. Ectoines in cell stress protection: uses and biotechnological production. Biotechnol Adv. 2010;28(6):782–801. https://doi.org/10.1016/j.biotechadv.2010.06.005.; Bow JR, Sonoki Y, Uchiyama M, Dauskardt RH. Ectoine disperses keratin and alters hydration kinetics in stratum corneum. Biochem Biophys Rep. 2021;28:101134. https://doi.org/10.1016/j.bbrep.2021.101134.; Kauth M, Trusova OV. Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review. Dermatol Ther. 2022;12(2):295–313. https://doi.org/10.1007/s13555-021-00676-9.; Jiang Q, Wang Y, Liu Y, Zhu D, Xie Y, Zhao J et al. Prevalence and associated factors of dry skin among older inpatients in hospitals and nursing homes: a multicenter cross-sectional study. Int J Nurs Stud. 2022;135:104358. https://doi.org/10.1016/j.ijnurstu.2022.104358.
-
17Academic Journal
Authors: VASILACHE, Eugenia, TURCAN, Lucia, PODGURSCHI, Lilia, GUȚU, Ina, CARACAS, Anastasia, MIHALACHI-ANGHEL, Maria, BACINSCHI, Nicolae
Source: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 79 No. 2 (2024): Medical Sciences; 210-214 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 79 Nr. 2 (2024): Ştiinţe medicale; 210-214 ; Вестник Академии Наук Молдовы. Медицина; Том 79 № 2 (2024): Медицина; 210-214 ; 1857-0011
Subject Terms: заболевание легких, токсичность, побочные эффекты, afecţiuni pulmonare, toxicitate, reacţii adverse, lung diseases, toxicity, side effects
File Description: application/pdf
Relation: https://bulmed.md/bulmed/article/view/3696/3687; https://bulmed.md/bulmed/article/view/3696
-
18Academic Journal
Authors: Vasilache, E., Ţurcan, L.M., Podgurschi, L., Podgursky, L., Guţu, I.A., Caracaş, A., Mihalachi-Anghel, M., Bacinschi, N.G., Bachinsky, N.
Source: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 79 (2) 210-214
Subject Terms: side effects, Токсичность, побочные эффекты, afecţiuni pulmonare, toxicity, заболевание легких, toxicitate, reacţii adverse, lung diseases
File Description: application/pdf
Access URL: https://ibn.idsi.md/vizualizare_articol/218019
-
19Academic Journal
Authors: N. Ya. Siritsa
Source: Качественная клиническая практика, Vol 0, Iss 2, Pp 85-90 (2023)
Subject Terms: RS1-441, 0301 basic medicine, 03 medical and health sciences, лекарственно-индуцированная нейротоксичность, Pharmacy and materia medica, 0302 clinical medicine, побочные эффекты, Medical technology, R855-855.5, болезнь паркинсона, кислородные радикалы, нейротоксичность, 3. Good health
-
20Academic Journal
Source: Медицина в Кузбассе, Vol 23, Iss 1, Pp 5-10 (2024)
Subject Terms: ингибиторы протонной помпы, лекарственная безопасность, побочные эффекты, внебольничная пневмония, новая коронавирусная инфекция (covid-19), бронхиальная астма, хроническая обструктивная болезнь легких, Medicine
File Description: electronic resource